RxDoctor Payments Data

Jesse Sheldon, PA

Physician Assistant · Lakewood, CONPI 1073140190

Payments from drug & device makers

$1,931in general payments, 2019–2025

Across 85 payments — averaging $22.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$498
  • Pfizer$283
  • Collegium Pharmaceutical, Inc.$211
  • SPR Therapeutics, Inc$186
  • Globus Medical$108
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$107
  • plus $537 from 12 others

What the payments were for

  • Food & beverage$1,931100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,931 in reported general payments places this provider in the 85th percentile of 2,849 physician assistant providers in Colorado.

See all physician assistant providers in Colorado

Medicare billing

Part B allowed, 2024
$27,294
Medicare patients
73
Services billed
1,090

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl20$16,388
Xtampza ErOxycodone Myristate17$8,395
Lidocaine59$6,742
ZtlidoLidocaine17$6,145
Buprenorphine20$5,148
OxycontinOxycodone Hcl13$2,944
Oxycodone Hcl135$2,495
Gabapentin129$2,371
Morphine Sulfate ErMorphine Sulfate78$1,924
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen76$1,835
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen49$1,751
Pregabalin64$1,710
Tramadol Hcl16$1,494
Celecoxib56$1,483
Diclofenac Sodium27$1,132

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$211$24,78337 claims
Scilex Pharmaceuticals Inc.Ztlido$79$6,14517 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,849 physician assistant providers in Colorado.

Other physician assistant in Lakewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →